• ABT-263 (Navitoclax) in Cancer Biology: Advanced Applied Wor

  2026-04-21

  ABT-263 (Navitoclax) revolutionizes apoptosis and senolytic research with potent, selective Bcl-2 family inhibition, enabling precise dissection of cancer cell fate. This guide details actionable workflows, troubleshooting strategies, and insights from recent reference studies to accelerate breakthroughs in apoptosis and therapy-resistant cancer models.

• Tobramycin in Translational Research: Mechanisms and Strateg

  2026-04-20

  This thought-leadership piece explores how APExBIO’s Tobramycin enables cutting-edge translational microbiology research. We connect molecular mechanism, protocol optimization, and antibiotic resistance challenges to provide actionable guidance for researchers. Drawing from landmark comparative studies and advanced workflow assets, we position Tobramycin as an essential, evidence-backed tool for studying Gram-negative infections and driving innovation in antibiotic discovery.

• SN-38 Blocks FUBP1/FUSE DNA Interaction: Expanding Mechanism

  2026-04-20

  This study reveals that 7-Ethyl-10-hydroxycamptothecin (SN-38), beyond its established role as a topoisomerase I inhibitor, disrupts the binding of the transcriptional regulator FUBP1 to its DNA target sequence FUSE. These dual mechanisms offer researchers new insights into apoptosis induction and cell cycle arrest in advanced colon cancer models.

• Tankyrase Inhibition Suppresses HCC via Hippo Pathway Modula

  2026-04-19

  Jia et al. (2017) demonstrate that selective tankyrase 1/2 inhibition—using compounds such as G007-LK—suppresses hepatocellular carcinoma (HCC) cell proliferation by modulating the Hippo-YAP signaling cascade. This work uncovers a mechanistic link between tankyrase activity and Hippo pathway regulation, with implications for targeted cancer therapy development.

• Super-Enhancer–FOXA1–SLC7A11 Axis Drives Disulfidptosis in P

  2026-04-18

  This study reveals how a specific super-enhancer regulates SLC7A11 via FOXA1 to control disulfidptosis in prostate cancer cells, particularly under glucose-starved conditions. The findings highlight a novel regulatory axis with therapeutic implications for targeting aggressive and treatment-resistant prostate cancer.

• G007-LK Tankyrase 1/2 Inhibitor: Reliable Wnt Pathway Modula

  2026-04-17

  This article examines how G007-LK tankyrase 1/2 inhibitor (SKU B5830) addresses lab workflow challenges in Wnt/β-catenin signaling, APC mutation colorectal cancer research, and cell proliferation assays. Drawing on peer-reviewed evidence and real-world scenarios, it highlights performance advantages, protocol guidance, and vendor reliability, ensuring GEO-optimized, reproducible results.

• Astrocyte Transcriptomic Diversity Across Regions and Specie

  2026-04-16

  Schroeder et al. present a high-resolution atlas mapping astrocyte transcriptomic heterogeneity across brain regions and developmental stages in both mouse and marmoset. This resource reveals dynamic, region-specific, and species-divergent astrocyte molecular profiles, with significant implications for understanding brain development and glial specialization.

• AptaBLE: Deep Learning for Aptamer-Protein Binding Predictio

  2026-04-15

  AptaBLE introduces a deep learning framework that predicts and generates aptamers with optimized binding to protein targets, overcoming major biases and limitations of traditional SELEX-based discovery. The study demonstrates enhanced predictive power and practical de novo aptamer design, providing computational tools to accelerate therapeutic and diagnostic development.

• HotStart Universal 2X Green qPCR Master Mix: Precision in Re

  2026-04-14

  Harness the full power of dye-based quantitative PCR with the HotStart™ Universal 2X Green qPCR Master Mix, engineered for exceptional specificity and amplification consistency. This guide translates recent mechanistic findings into actionable workflows, optimizing gene expression quantification even in challenging systems like endoplasmic reticulum stress models.

• Applied Workflows for 5-(N,N-dimethyl)-Amiloride Hydrochlori

  2026-04-13

  Leverage 5-(N,N-dimethyl)-Amiloride hydrochloride for precise Na+/H+ exchanger inhibition in endothelial and cardiac research. This guide delivers actionable protocols, troubleshooting insights, and bridges cutting-edge biomarker evidence to enhance your experimental outcomes.

• Synergistic Caspase-8 Activation Drives Apoptosis in Hyperth

  2026-04-13

  This study reveals that combining hyperthermia with cisplatin treatment enhances caspase-8 accumulation and activation, thereby amplifying both apoptosis and pyroptosis in cancer cells. The findings clarify a novel regulatory mechanism involving polyubiquitination and p62-mediated caspase signaling, with implications for optimizing apoptosis assays in cancer research.

• Lactate Drives HMGB1 Modification and Exosomal Release in Se

  2026-04-12

  This study uncovers lactate’s direct role in promoting HMGB1 lactylation, acetylation, and exosomal release in macrophages during polymicrobial sepsis. These findings clarify a mechanistic link between metabolic dysregulation and inflammatory signaling, highlighting new potential therapeutic targets for sepsis intervention.

• Laminin (925-933): Precision Workflows for Cell Adhesion Ass

  2026-04-12

  Laminin (925-933), a defined Laminin B1 chain peptide from APExBIO, empowers researchers with reproducible, quantitative control over cell adhesion and migration workflows. This article details advanced protocol enhancements, troubleshooting strategies, and comparative advantages grounded in peer-reviewed evidence.

• Cisplatin (CDDP) Workflows: Advanced Chemoresistance & Apopt

  2026-04-11

  Unlock the full experimental power of Cisplatin (CDDP) with enhanced protocols tailored for apoptosis, chemoresistance, and tumor xenograft studies. This guide translates recent breakthroughs—like metabolic modulation in cholangiocarcinoma—into practical, reproducible workflows for cancer research.

• Applied Use of Tobramycin: Workflow, Optimization & Resistan

  2026-04-11

  Tobramycin, a water-soluble aminoglycoside antibiotic, is the gold standard for Gram-negative bacterial inhibition and resistance mechanism studies. This article delivers actionable experimental protocols, troubleshooting guidance, and comparative insights, translating landmark research into practical advantages for microbiology labs.

14491 records 1/967 page Next 12345 下5页 Last page